In this episode, guest Amy S. Paller, MD, MS, discusses warning signs of measles, protocols physicians should take and more.
· Intro 0:28
· Amy S. Paller, MD, MS 0:38
· Can you give us your perspective as a clinician on what the presentation of measles is, and what clinicians should think about this? 1:49
· How would you diagnose measles? 4:43
· How long is the quarantine period for those who have been exposed to a case of measles? 6:13
· Gelfand and Paller on measles exposure and vaccination status. 7:30
· What is the treatment for measles? 8:34
· Gelfand and Paller on newborns' vulnerability to this disease. 10:07
· How much is temporary immune amnesia going to be a problem for people who experience more susceptibility after being diagnosed with measles? 12:28
· Thanks for listening. 13:20
Amy S. Paller, MD, MS, is the Walter J. Hamlin professor and chair of dermatology and professor of pediatrics and director of the Skin Biology and Diseases Resource-based Center at Northwestern University's Feinberg School of Medicine.
We'd love to hear from you! Send your comments/questions to Dr. Gelfand at podcasts@healio.com. Follow Dr. Gelfand on LinkedIn.
For more, be sure to visit the Beneath the Surface video blog on Healio.com.
Disclosures: Gelfand is Chief Medical Editor of Healio Dermatology. Paller reports having investigator roles with AbbVie, BioMendics, Dermavant, Eli Lilly, Incyte, Johnson & Johnson Innovative Medicine, Regeneron and UCB; consulting roles with Abeona, Arcutis, BioCryst, Boehringer-Ingelheim, Castle Creek, Chiesi, Dermavant, Johnson & Johnson Innovative Medicine, Krystal, LEO Pharma, Lilly, L'Oreal, MoonLake Immunotherapeutics, Pelthos, Quoin, Regeneron and Sanofi; and data safety monitoring board roles with AbbVie, Abeona, BioCryst, Daiichi, Sankyo and Galderma.
